fashion -WSS

fashion

author：Wikipedia 2025-09-28 15:55:27 - browse：8

Paul Berggreen, a gastroenterologist at Arizona Digestive Health who formed a new lobbying group for independent physician practices. Arizona Digestive Health/ GI Alliance

Private equity gets a bad rap in health care. But some doctors see that kind of cash and consolidation as the only way for their practices to survive — and now, they’re taking that message to Washington.

Lower pay, difficult negotiations with insurance companies, regulatory requirements from both government and commercial payers, expensive and inefficient IT systems, and the challenge of competing against hospital systems have created a “cascade of problems that seem like they are almost insurmountable” for independent practices, said Paul Berggreen, a gastroenterologist at Arizona Digestive Health.

Berggreen is joining with other doctors to start a lobbying group for private practices, the brand-new American Independent Medical Practice Association, or AIMPA, to fight against those problems and advocate for private practice physicians.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： Readout LOUD podcast: ASCO preview, a Duchenne trial failure

WSS

For one rare type of lung cancer, Pfizer pill reduces progression by 81%

FDA's Pazdur wants cancer trials to range beyond China alone

Innovation in antibiotics is ailing. 'Brain drain' may kill it

Unique patient identifier: Experts argue the benefits, pitfalls

What’s missing from the debate over nursing home staff minimums

At ASCO, pharma leaders speak of advances in 'smart bomb' drugs

focus

fashion

hotspot

Novavax promises a turnaround & Lilly roils the obesity market

Why Novartis is going to walk from its acquisition of MorphoSys

Anesthesiologist group: stop taking Ozempic before surgery

Medicare Advantage plans can’t deny care with AI, CMS warns

What does generative AI mean for health care? We asked experts

ASCO24: AstraZeneca won cancer’s big meeting. Can it fulfill its $80B ambition?

Supreme Court strikes down use of affirmative action

Why Novartis is going to walk from its acquisition of MorphoSys

United colonoscopy coverage change 'may cost lives,' doctors say

Why CTE doesn’t keep Americans from enjoying the Super Bowl

leisure time

340B reform proposal comes out of Senate working group

Padmanee Sharma of MD Anderson at center of lawsuit over credit

Novo Holdings to buy drug manufacturer Catalent in $16.5B deal

At ASCO, AstraZeneca reports strong data for breast cancer drug

Texas Medical Board asked to define abortion emergency exception

Let's speed up science by embracing open access publishing

Wikipedia

Wikipedia

knowledge

entertainment